Welcome

Thank you for your interest in participating in this survey about your experience with Idiopathic Intracranial Hypertension (IIH).

This survey is sponsored by NBO Pharma and conducted by Engage Health, Inc., an independent health research company. NBO Pharma is developing a new treatment for IIH and has created IIHConnect.com, an online resource designed to provide patients, caregivers, healthcare professionals, and others with reliable, up-to-date information about IIH.

The purpose of this survey is to better understand the experiences, needs, and questions of people living with IIH. The information you share will help inform future educational content and resources available through IIHConnect, including an AI-developed knowledge base.

NBO Pharma will not receive your individual survey responses or any information that could identify you. De-identified, aggregated results may be shared with NBO Pharma for research and reporting purposes.

Who can participate in the survey? 
To be eligible to participate in the survey, you must:
-Reside in the US.
-Be diagnosed with Idiopathic Intracranial Hypertension (IIH).
-Be able to provide informed consent.
-Be willing to complete this web-based survey, which will take approximately 20 minutes.  

You will receive compensation if you participate.
Upon completion of the survey, you will receive a $100 honorarium (via check) as a thank you for your time and participation.

How do I begin the Survey?
Hit "Next" at the bottom of this page to proceed to the survey. 

If you have questions, please contact Engage Health at the number below.  Thank you for your interest!  Please note that spaces are limited, so please complete your survey if you would like to be included!

Thank you!

Patti Engel
President and CEO
Engage Health, Inc.
651-994-0510 (Office)
pengel@engagehealth.com